Apelin, C-reactive protein, and serum protein correlation with blood pressure ‒ a biomarker analysis
DOI:
https://doi.org/10.15584/ejcem.2025.4.16Keywords:
adipokines, albumin, apelin, blood pressure, C-reactive proteinAbstract
Introduction and aim. Hypertension is a major global health burden and a leading cause of cardiovascular disease and premature death. This study aimed to evaluate the association between serum apelin, inflammatory markers, and protein metabolism parameters in hypertensive patients compared to normotensive controls. This study uniquely explores the interplay between inflammatory and protein metabolism biomarkers using advanced multivariate models in hypertensive adults, a combination not previously examined in this population
Material and methods. Two hundred adults aged 35–65 years were divided into hypertensive (n=100) and normotensive (n=100) groups. Serum apelin and C-reactive protein (CRP) levels were measured using enzyme-linked immunosorbent assay, while albumin and total protein were assessed via spectrophotometry. Statistical analyses included t-tests, multiple regression, structural equation modeling (SEM), and Cox regression.
Results. Hypertensive patients had significantly higher blood pressure (p<0.001), CRP (7.52±4.21 vs. 1.35±0.51 mg/L; p<0.001), globulin (3.4±1.0 vs. 1.8±0.9 g/dL; p<0.001), and total protein, but lower apelin (2386.2±401.7 vs. 2873.4±572.8 pg/mL; p<0.001) and albumin levels. SEM revealed a direct association between CRP and systolic blood pressure (β=0.45, p<0.001), and a negative association between apelin and systolic pressure (β=−0.20, p=0.03). CRP (HR=1.75, p=0.005) and systolic BP (HR=1.52, p<0.001) were independent predictors of cardiovascular events.
Conclusion. The findings suggest that systemic inflammation and dysregulation of serum protein metabolism are significantly associated with hypertension and cardiovascular risk. Apelin may play a protective role by mitigating the impact of inflammation on blood pressure.
Downloads
References
Safar ME, Levy BI, Struijker-Boudier H. Current perspectives on arterial stiffness and pulse pressure in hypertension and cardiovascular diseases. Circulation. 2003;107(22):2864-2869. doi: 10.1161/01.cir.0000069826.36125.b4
Pan H, Hibino M, Kobeissi E, Aune D. Blood pressure, hypertension and the risk of sudden cardiac death: a systematic review and meta-analysis of cohort studies. Eur J Epidemiol. 2019;35(5):443-454. doi: 10.1007/s10654-019-00593-4
Mousa NAW, Khaleefah MA, Al-Badri HJ. Hypertension Control among Adult Iraqis. J Fac Med Baghdad. 2022;64(3):145-152. doi: 10.32007/jfacmedbagdad.6431935
Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nat Rev Nephrol. 2020;16(4):223-237. doi: 10.1038/s41581-019-0244-2
Tanaka M, Akiyama Y, Mori K, et al. Machine learning-based analyses of contributing factors for the development of hypertension: a comparative study. Clin Exp Hypertens. 2025;47(1):2449613. doi: 10.1080/10641963.2025.2449613
Salbookhh ZF, Ramadhan UH, Hassan GK. Adipokines identify crucial biomarkers for hypertension in Iraq. Academia Open. 2024;9(2):1-6. https://doi:10.21070/acopen.9.2024.8961
Würfel M, Blüher M, Stumvoll M, et al. Adipokines as clinically relevant therapeutic targets in obesity. Biomedicines. 2023;11(5):1427-1448. doi: 0.3390/biomedicines11051427
Folino A, Montarolo PG, Samaja M, Rastaldo R. Effects of apelin on the cardiovascular system. Heart Fail Rev. 2015;20(4):505-518. doi: 10.1007/s10741-015-9475-x
Snipelisky D, Jentzer J, Batal O, Dardari Z, Mathier M. Serum albumin concentration as an independent prognostic indicator in patients with pulmonary arterial hypertension. Clin Cardiol. 2018;41(6):782-787. doi: 10.1002/clc.22954
Ashraf MA, Shen B, Raza MA, et al. Albumin: A review of market trends, purification methods, and biomedical innovations. Curr Issues Mol Biol. 2025;47(5):303-326. doi: 10.3390/cimb47050303
Pai AY, Sy J, Kim J, et al. Association of serum globulin with all-cause mortality in incident hemodialysis patients. Nephrol Dial Transplant. 2021;37(10):1993-2003. doi: 10.1093/ndt/gfab292
Cabrerizo S, Cuadras D, Gómez‑Busto F, Artaza‑Artabe I, Marín‑Ciancas F, Malafarina V, et al. Serum albumin and health in older people: review and meta‑analysis. Maturitas. 2015;81(1):17-27. doi: 10.1016/j.maturitas.2015.02.009
Cho SY, Han J, Cha S-H, Yoon S-I. Structural basis of serum albumin recognition by SL335, an antibody Fab extending the serum half-life of protein therapeutics. Biochem Biophys Res Commun. 2020;526(4):941-946. doi: 10.1016/j.bbrc.2020.03.133
Djousse L, Rothman KJ, Cupples LA, Levy D, Ellison RC. Serum albumin and Risk of Myocardial Infarction and All-Cause Mortality in the Framingham Offspring Study. Circulation. 2002;106(23):2919-2924. doi: 10.1161/01.cir.0000042673.07632.76
Yin XY, Cai Y, Zhu ZH, et al. Associations of decreased serum total protein, albumin, and globulin with depressive severity of schizophrenia. Front Psychiatry. 2022;13:957671. doi: 10.3389/fpsyt.2022.957671
Cabrerizo S, Cuadras D, Gomez-Busto F, Artaza-Artabe I, Marín-Ciancas F, Malafarina V. Serum albumin and health in older people: Review and meta-analysis. Maturitas. 2015;81(1):17-27. doi: 10.1016/j.maturitas.2015.02.009
Keum M, Lee BC, Choe YM, et al. Protein intake and episodic memory: the moderating role of the apolipoprotein E ε4 status. Alzheimers Res Ther. 2024;16(1):181. doi: 10.1186/s13195-024-01546-0
Savoia C, Schiffrin EL. Inflammation in hypertension. Curr Opin Nephrol Hypertens. 2006;5(3):152-158. doi: 10.1097/01.mnh.0000203189.57513.76
Shreevastva NK, Makaju HS, Dhungana A, Pandeya A. Study of biochemical parameters and body mass index along with its associated risk factors among health science students: A cross-sectional study. Birat J Health Sci. 2020;5(3):1142-1147. doi: 10.3126/bjhs.v5i3.33683
Askin L, Askin HS, Tanrıverdi O, Ozyildiz AG, Duman H. Serum apelin levels and cardiovascular diseases. North Clin Istanb. 2022;9(3):290-294. doi: 10.14744/nci.2021.33427
Unger T, Borghi C, Charchar F, et al. 2020 International Society of Hypertension Global Hypertension Practice Guidelines. Hypertension. 2020;75(6):1334-1357. doi: 10.1161/HYPERTENSIONAHA.120.15026
Patel KK, Khera A, Das SR, et al. Prevalence of elevated cardiovascular risk in young adults in the United States. Ann Intern Med. 2017;166(8):553-560. doi: 10.7326/M16-2052
Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation. 2003;107(3):363-369. doi: 10.1161/01.cir.0000053730.47739.3c
Mohammadi M, Mohamadi M, Moradi A, et al. Apelin as a Candidate for Hypertension Management; A Systematic Review and Meta-Analysis on Animal Studies. Arch Acad Emerg Med. 2022;10(1):e90. doi: 10.22037/aaem.v10i1.1704
Chen Z, Song C, Yao Z, Sun J, Liu W. Associations between albumin, globulin, albumin to globulin ratio and muscle mass in adults: results from the national health and nutrition examination survey 2011–2014. BMC Geriatrics. 2022;22(1):383. doi: 10.1186/s12877-022-03094-4
Silva D, De Lacerda AP. High-sensitivity C-reactive protein as a biomarker of risk in coronary artery disease. Rev Port Cardiol. 2012;31(11):733-740. doi: 10.1016/j.repce.2012.09.006
Martins C, Neves B, Teixeira AS, et al. Identifying subgroups in heart failure patients with multimorbidity by clustering and network analysis. BMC Med Inform Decis Mak. 2024;24(1):95. doi: 10.1186/s12911-024-02497-0
Cox DR. Regression models and life‑tables. J Roy Stat Soc Ser B (Methodol). 1972;34(2):187-202. doi: 10.1111/j.2517-6161.1972.tb00899.x
Raichlin ER, McConnell JP, Lerman A, et al. Systemic inflammation and metabolic syndrome in cardiac allograft vasculopathy. J Heart Lung Transplant. 2007;26(8):826-833. doi: 10.1016/j.healun.2007.05.008
Huang H, Lin H, Zhang C, et al. Predictive value of CRP/albumin ratio in patients with sepsis: A meta-analysis. Front Med (Lausanne). 2021;8:702408. doi: 10.3389/fmed.2021.702408
Zhang Z, Zhang X, Li Y, et al. Circulating apelin levels and cardiovascular disease: A systematic review and meta-analysis. Int J Cardiol. 2018;264:29-36. doi: 10.1016/j.ijcard.2018.03.021
Balbino B, Conde E, Marichal T, Starkl P, Reber LL. Approaches to target IgE antibodies in allergic diseases. Pharmacol Ther. 2018;191:50-64. doi: 10.1016/j.pharmthera.2018.05.013
Oto J, Fernández‑Pardo Á, Miralles M, et al. Activated protein C assays: a review. Clin Chim Acta. 2020;502:227-232. doi: 10.1016/j.cca.2019.11.005
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 European Journal of Clinical and Experimental Medicine
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our open access policy is in accordance with the Budapest Open Access Initiative (BOAI) definition: this means that articles have free availability on the public Internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from having access to the Internet itself.
All articles are published with free open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0). If you submit your paper for publication by the Eur J Clin Exp Med, you agree to have the CC-BY license applied to your work. Under this Open Access license, you, as the author, agree that anyone may download and read the paper for free. In addition, the article may be reused and quoted provided that the original published version is cited. This facilitates freedom in re-use and also ensures that Eur J Clin Exp Med content can be mined without barriers for the research needs.
